Galapagos NV GLPG:NASDAQ

RT Quote | NASDAQ | USD
Last | 08/09/22 EDT
53.27quote price arrow down-0.83 (-1.53%)
Volume
149,876
52 week range
46.41 - 72.11
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close53.27
  • 52 Week High72.11
  • 52 Week High Date04/07/22
  • 52 Week Low46.41
  • 52 Week Low Date12/03/21

Key Stats

  • Market Cap3,595.35M
  • Shares Out65.73M
  • 10 Day Average Volume0.22M
  • Dividend-
  • Dividend Yield-
  • Beta0.01
  • YTD % Change-3.37

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close53.27
  • 52 Week High72.11
  • 52 Week High Date04/07/22
  • 52 Week Low46.41
  • 52 Week Low Date12/03/21
  • Market Cap3,595.35M
  • Shares Out65.73M
  • 10 Day Average Volume0.22M
  • Dividend-
  • Dividend Yield-
  • Beta0.01
  • YTD % Change-3.37

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date11/03/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Galapagos NV

There is no recent news for this security.

Content From Our Affiliates

Profile

MORE
Galapagos NV is a Belgium-based clinical-stage biotechnology company. The Company is focused on the discovery and development of small molecule medicines with novel modes of action. Its pipeline comprises Phase 3, 2, 1, pre-clinical studies and discovery small-molecule and antibody programs in cystic fibrosis, inflammation, and other indications. The Company aims to develop a portfolio of clinical-stage therapies for the enhancement of existing treatment paradigms. In...
Paulus Stoffels
Chairman of the Board, Chief Executive Officer
Bart Filius
President, Chief Financial Officer, Chief Operating Officer, Member of the Management Board
Address
Generaal De Wittelaan 3
Malines (mechelen)
2800
Belgium

Top Peers

SYMBOLLASTCHG%CHG
ABCL
Abcellera Biologics Inc
11.11-0.65-5.53%
PTCT
PTC Therapeutics Inc
51.72-1.69-3.16%
FOLD
Amicus Therapeutics Inc
12.36-0.18-1.44%
RARE
Ultragenyx Pharmaceutical Inc
51.37-1.26-2.39%
ACAD
ACADIA Pharmaceuticals Inc
16.22-0.40-2.41%